Menu
Menu
19 Harley St, London, W1G 9QJ, UK
We are London's Top Spine Clinic

P16INK4a gene promoter methylation as a biomarker for the analysis of non-small cell lung most cancers: An up to date meta-analysis.

Related Articles

P16INK4a gene promoter methylation as a biomarker for the analysis of non-small cell lung most cancers: An up to date meta-analysis.

Thorac Most cancers. 2018 Jun 21;:

Authors: Tuo L, Sha S, Huayu Z, Du Okay

Summary
BACKGROUND: This meta-analysis was carried out to analyze the diagnostic efficiency of P16INK4a gene promoter methylation as a biomarker of non-small cell lung most cancers (NSCLC).
METHODS: Two reviewers independently searched the Net of Science, PubMed, Cochrane, Embase, China Nationwide Information Infrastructure, and Chinese language Biomedical Literature databases. Publications related to P16INK4a gene promoter methylation in serum or bronchoalveolar fluid/sputum have been screened and included on this meta-analysis. Pooled diagnostic sensitivity, specificity, and symmetric receiver working attribute curve have been calculated.
RESULTS: Twenty-six publications with 1768 lung most cancers circumstances and 1323 controls have been included. The pooled sensitivity, specificity, optimistic and adverse chance ratios, and diagnostic odds ratio have been Zero.46 (95% confidence interval [CI] Zero.43-Zero.48), Zero.90 (95% CI Zero.88-Zero.91), 6.33 (95% CI three.89-10.30), Zero.57 (95% CI Zero.50-Zero.65) and 10.72 (95% CI 6.94-16.56), respectively, for P16INK4a gene promoter methylation as a biomarker for the analysis of NSCLC. The world underneath the symmetric receiver working attribute curve was Zero.75 with a typical error of Zero.004. No publication bias was detected through line regression check (t?=?Zero.95; P?=?Zero.35) and Begg’s funnel plot.
CONCLUSION: P16INK4a gene promoter methylation detection in serum or bronchoalveolar fluid/sputum could also be a possible biomarker for NSCLC analysis; nonetheless, the sensitivity was comparatively low, which isn’t appropriate for NSCLC screening.

PMID: 29927090 [PubMed – as supplied by publisher]

Share to care...

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on google
Google+
Share on linkedin
LinkedIn
Share on skype
Skype

What we do...

The Harley Street Hospital

Testimonials

What is London spine unit and How it Works

The London Spine Unit was established in 2005 and has successfully treated over 5000 patients. All conditions are treated.

We treat all spinal disorders

The London Spine Unit specialises in Minimally Invasive Treatments allowing rapid recovery and return to normal function

Trusted by patients worldwide

The London Spine Unit provides the highest quality care to all patients and has VIP services for those seeking exceptional services

What our patients say about us ......

Facet arthropathy patient

They were very professional with good communication between doctor and patient. I also received correspondence after each consultation. Oscar F. You May Also Like:Patient following

Read More »

Transforaminal Epidural

Comfortable environment – all nurses, anaesthetist, doctor made me feel at ease. Paul S. You May Also Like:Three-Level Lumbar Decompression Surgery for Low Back PainSevere

Read More »